Friday, September 15, 2017 7:56:20 AM
RXII - .523
BZ: BioAxone in Collaboration with RXi Pharma is Awarded a $1.8M Grant from the National Institute of Neurological Disorders and Stroke
BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury
BZ: BioAxone in Collaboration with RXi Pharma is Awarded a $1.8M Grant from the National Institute of Neurological Disorders and Stroke
BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
